Compare, Analyse AJANTA PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   MYLAN
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
MYLAN
Dec-18
AJANTA PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,4223,561-   
Low Rs8981,960-   
Sales per share (Unadj.) Rs233.51,638.8-  
Earnings per share (Unadj.) Rs44.044.5-  
Cash flow per share (Unadj.) Rs52.2351.3-  
Dividends per share (Unadj.) Rs9.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs255.11,772.8-  
Shares outstanding (eoy) m88.02514.50-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.01.7 294.8%   
Avg P/E ratio x26.462.0 42.5%  
P/CF ratio (eoy) x22.27.9 283.0%  
Price / Book Value ratio x4.51.6 292.0%  
Dividend payout %20.50-   
Avg Mkt Cap Rs m102,0811,420,461 7.2%   
No. of employees `0006.835.0 19.4%   
Total wages/salary Rs m4,3070-   
Avg. sales/employee Rs Th3,022.624,089.9 12.5%   
Avg. wages/employee Rs Th633.40-   
Avg. net profit/employee Rs Th569.1654.1 87.0%   
INCOME DATA
Net Sales Rs m20,554843,147 2.4%  
Other income Rs m2110-   
Total revenues Rs m20,765843,147 2.5%   
Gross profit Rs m5,664218,175 2.6%  
Depreciation Rs m721157,870 0.5%   
Interest Rs m1240,552 0.0%   
Profit before tax Rs m5,14319,752 26.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273-3,142 -40.5%   
Profit after tax Rs m3,87022,895 16.9%  
Gross profit margin %27.625.9 106.5%  
Effective tax rate %24.8-15.9 -155.6%   
Net profit margin %18.82.7 693.3%  
BALANCE SHEET DATA
Current assets Rs m11,812470,812 2.5%   
Current liabilities Rs m3,776343,274 1.1%   
Net working cap to sales %39.115.1 258.5%  
Current ratio x3.11.4 228.1%  
Inventory Days Days7784 92.6%  
Debtors Days Days8293 87.4%  
Net fixed assets Rs m14,398163,557 8.8%   
Share capital Rs m175449 39.1%   
"Free" reserves Rs m22,2770-   
Net worth Rs m22,452912,131 2.5%   
Long term debt Rs m7984,482 0.0%   
Total assets Rs m26,9622,446,689 1.1%  
Interest coverage x444.31.5 29,879.7%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 221.2%   
Return on assets %14.42.6 555.1%  
Return on equity %17.22.5 686.7%  
Return on capital %23.03.2 721.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,5800-   
CASH FLOW
From Operations Rs m3,748175,206 2.1%  
From Investments Rs m-2,228-90,562 2.5%  
From Financial Activity Rs m-1,475-81,621 1.8%  
Net Cashflow Rs m451,452 3.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare AJANTA PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: GSK PHARMA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AJANTA PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AJANTA PHARMA

AJANTA PHARMA 8-QTR ANALYSIS

COMPARE AJANTA PHARMA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS